Explore more
News
Moderna, COVID and FDA
Digest more
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback